Warner Rosalie C, Chapman Ryan C, Davis Brianna N, Davis Paul H
Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, 68182.
J Parasitol. 2021 Nov 1;107(6):882-903. doi: 10.1645/20-157.
Toxoplasma gondii is an apicomplexan parasite that affects both humans and livestock. Transmitted to humans through ingestion, it is the second-leading cause of foodborne illness-related death. Currently, there exists no approved vaccine for humans or most livestock against the parasite. DNA vaccines, a type of subunit vaccine which uses segments of the pathogen's DNA to generate immunity, have shown varying degrees of experimental efficacy against infection caused by the parasite. This review compiles DNA vaccine efforts against Toxoplasma gondii, segmenting the analysis by parasite antigen, as well as a review of concomitant adjuvant usage. No single antigenic group was consistently more effective within in vivo trials relative to others.
弓形虫是一种顶复门寄生虫,可感染人类和家畜。它通过摄入传播给人类,是食源性疾病相关死亡的第二大原因。目前,尚无针对人类或大多数家畜的经批准的抗该寄生虫疫苗。DNA疫苗是一种亚单位疫苗,利用病原体的DNA片段产生免疫力,已显示出对该寄生虫引起的感染有不同程度的实验疗效。本综述汇编了针对弓形虫的DNA疫苗研究成果,按寄生虫抗原进行分析,并综述了佐剂的使用情况。在体内试验中,没有一个单一的抗原组始终比其他组更有效。